Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD

Slides:

Advertisements

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Advertisements

Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

What drives prescription patterns in pediatric asthma management?

Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity Andrei Malinovschi,

Obesity and pulmonary function testing

Advances in Diagnosing Peanut Allergy

Allergen immunotherapy: A practice parameter third update

Clarification concerning amoxicillin skin testing

Effects of time, albuterol, and budesonide on the shape of the flow-volume loop in children with asthma Anand C. Patel, MD, Mark L. Van Natta, MHS, James.

Fatty acids, inflammation, and asthma

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Ann-Marie M. Schoos, MD, PhD, Jacob D

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life? Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Is 9 more than 2 also in allergic airway inflammation?

Desensitization to Chemotherapeutic Agents

Fatty acids, inflammation, and asthma

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Allergy testing in predicting outcome of open food challenge to peanut

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients William W. Busse, MD, Sally E. Wenzel, MD, Eli O. Meltzer,

Advances in Diagnosing Peanut Allergy

Nonadherence to Asthma Treatment: Getting Unstuck

Peter M. Wolfgram, MD, David B. Allen, MD

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Reply Journal of Allergy and Clinical Immunology

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Sheena D. Brown, PhD, MSCR, Katherine M. Baxter, BS, Susan T

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think Martin L. Moore, PhD, R.

Lisa G. Wood, PhD, Manohar L. Garg, PhD, Peter G. Gibson, MBBS

What is an “eosinophilic phenotype” of asthma?

Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma Sheena D. Brown, PhD, Lou Ann Brown, PhD, Susan Stephenson, PhD,

Cephalosporin Side Chain Cross-reactivity

Medication use in children with asthma in Finland from 1995 to 2006

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

One step forward, 2 steps back: The enigma of preschool wheeze

Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma Anne M. Fitzpatrick, PhD, Lou.

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Anne M. Fitzpatrick, PhD, Youngja Park, PhD, Lou Ann S

Reply Journal of Allergy and Clinical Immunology

Measles and immunomodulation

Macrolide antibiotics and asthma treatment

Asthma: The past, future, environment, and costs

Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization.

Environmental factors and eosinophilic esophagitis

News & Notes Journal of Allergy and Clinical Immunology

The GILL study: Glycerin-induced local reactions in immunotherapy

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

Advances in pediatric asthma in 2007

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Negative affect, medication adherence, and asthma control in children

Safety and efficacy of repeated monthly carboplatin desensitization

Natural history of cow’s milk allergy

Progression of asthma in childhood

Primary prevention of asthma and allergy

Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and.

The Editors' Choice Journal of Allergy and Clinical Immunology

Presentation transcript:

Progressive airflow limitation is a feature of children with severe asthma Anne M. Fitzpatrick, PhD, MSCR, W. Gerald Teague, MD Journal of Allergy and Clinical Immunology Volume 127, Issue 1, Pages 282-284 (January 2011) DOI: 10.1016/j.jaci.2010.10.036 Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Calculated change per year in prebronchodilator and postbronchodilator FEV1 (shown in liters; A and B), FVC (shown in liters; B and C), and FEV1/FVC ratio (shown as percent predicted; E and F). Lines represent the mean. MMA, Mild-to-moderate asthma; SA, severe asthma. ∗P < .05 and ∗∗P ≤ .01. Journal of Allergy and Clinical Immunology 2011 127, 282-284DOI: (10.1016/j.jaci.2010.10.036) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Calculated yearly change in postbronchodilator FEV1 percent predicted values in children with mild-to-moderate and severe asthma. Lines represent the mean. ∗P < .05. Journal of Allergy and Clinical Immunology 2011 127, 282-284DOI: (10.1016/j.jaci.2010.10.036) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions